Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02595489 · ClinicalTrials.gov registry record · Phase 1
A Pilot Study of Vitamin D in Boys With X-linked Adrenoleukodystrophy
A Phase 1 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 1
- Development phase
- 21
- Enrollment target
NCT02595489: Completed Phase 1 study, sponsored by Stanford University.
NCT02595489 is a Phase 1 study that has completed, run by Stanford University. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02595489, a Phase 1 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 21 participants
- Enrollment target
Study Summary
In this pilot study, the investigators will assess the safety of two high-dose regimens of oral vitamin D supplementation and measure the effects of vitamin D supplementation on markers of oxidative stress and inflammation in the blood and brain of study participants before, during, and after taking vitamin D supplements. The goal of the study is to establish research measures (i.e. biomarkers) and an optimal dose for vitamin D supplementation in boys with the X-linked adrenoleukodystrophy (ALD) genotype.
Interventions
- DIETARY_SUPPLEMENT vitamin D3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2016-11-21 |
| Est. Completion | 2020-06-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02595489
The ClinicalTrials.gov registry entry for NCT02595489 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which vitamin D3 is the first listed.
NCT02595489 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02595489 about?
NCT02595489 is a clinical study titled "A Pilot Study of Vitamin D in Boys With X-linked Adrenoleukodystrophy". In this pilot study, the investigators will assess the safety of two high-dose regimens of oral vitamin D supplementation and measure the effects of vitamin D supplementation on markers of oxidative stress and inflammation in the blood and brain of study participants before, during, and after taking...
What is the current status of trial NCT02595489?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 21 participants. The study started on 2016-11-21. Estimated completion is 2020-06-30.
What interventions are being tested in trial NCT02595489?
The interventions under investigation include: vitamin D3 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02595489?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.